Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Cancer Research|June 1, 1987
Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activityK Hori, M J Ehrke, K Mace, et al.
Hematological Oncology|January 1, 1987
In vitro production of granulocyte-macrophage colony-stimulating activity by murine bone marrow and spleen following vinblastine administration in vivoD E Williams, D S Chervinsky, F R Orsini, et al.
Oncology Research|January 1, 1994
Intracellular doxorubicin kinetics in lymphoma cells and lymphocytes infiltrating the tumor area in vivo: a flow cytometric studyG Zaleskis, R L Ho, P Diegelman, et al.
The Journal of Urology|June 1, 1994
Effect of perioperative chemoimmunotherapy with cyclophosphamide and autologous tumor vaccine in murine MBT-2 bladder cancerT S Tzai, R P Huben, G Zaleskis, et al.
International Journal of Cancer|June 22, 2000
Protective specific immunity induced by doxorubicin plus TNF-alpha combination treatment of EL4 lymphoma-bearing C57BL/6 miceM J Ehrke, S Verstovsek, D L Maccubbin, et al.
International Journal of Immunopharmacology|January 1, 1988
Comparison of adriamycin induced immunomodulation with that of the noncardiotoxic anthracycline 5-iminodaunorubicinD L Maccubbin, J A Whitman, N Taniguchi, et al.
International Journal of Cancer|November 3, 1995
Cyclophosphamide plus tumor necrosis factor-alpha chemoimmunotherapy cured mice: life-long immunity and rejection of re-implanted primary lymphomaM J Ehrke, S Verstovsek, C M Krawczyk, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1996
Specific anti-EL4-lymphoma immunity in mice cured 2 years earlier with doxorubicin and interleukin-2M J Ehrke, S Verstovsek, G Zaleskis, et al.
Cancer Research|July 1, 1992
Adriamycin-induced modulation of host defenses in tumor-bearing miceD L Maccubbin, K R Wing, K F Mace, et al.
Oncology Research|January 1, 1993
Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphomaR L Ho, D L Maccubbin, P Ujházy, et al.
Pageof 8